Radiopharm Theranostics: The tip of the spear in cancer fighting technologies! 

Listen to ASX-listed Radiopharm Theranostics Exec Chairman Paul Hopper talk to Matt Birney on the Bulls N’ Bears Report about Radiopharm’s $150m ASX listing that will develop a range of cancer fighting technologies based on “radiopharmaceuticals”.

Radiopharm Theranostics: The tip of the spear in cancer fighting technologies!&nbsp;
Listen to ASX-listed Radiopharm Theranostics Exec Chairman Paul Hopper talk to Matt Birney on the Bulls N&rsquo; Bears Report about Radiopharm&rsquo;s $150m ASX listing that will develop a range of cancer fighting technologies based on &ldquo;radiopharmaceuticals&rdquo;.

Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Perth and Western Australia. Bulls N’ Bears covers public company news, views and CEO interviews across a number of main stream media platforms in WA. Its financial markets followers, who come from all four corners of the globe, are looking to zero in on Western Australia’s unique international status as the most prolific developer of small capped publicly listed companies in the world.

Matt Birney and Bulls N' Bears sit at the epicentre of the small cap ASX-listed company space in Perth and Western Australia. Bulls N&rsquo; Bears covers public company news, views and CEO interviews across a number of main stream media platforms in WA. Its financial markets followers, who come from all four corners of the globe, are looking to zero in on Western Australia&rsquo;s unique international status as the most prolific developer of small capped publicly listed companies in the world.

Advertisement